ALPRAZOLAM- alprazolam tablet 
Aphena Pharma Solutions - Tennessee, LLC



Alprazolam (al pra' zoe lam) Tablets, USP C-IV

What is the most important information I should know about alprazolam tablets?

What are alprazolam tablets?

Do not take alprazolam tablets if:

Before you take alprazolam tablets, tell your healthcare provider about all of your medical conditions, including if you:

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Taking alprazolam tablets with certain other medicines can cause side effects or affect how well alprazolam tablets or the other medicines work. Do not start or stop other medicines without talking to your healthcare provider.

How should I take alprazolam tablets?

What should I avoid while taking alprazolam tablets?

What are the possible side effects of alprazolam tablets?

Alprazolam tablets may cause serious side effects, including:

The most common side effects of alprazolam tablets include drowsiness and light-headedness. These are not all the possible side effects of alprazolam tablets. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

How should I store alprazolam tablets?

General information about the safe and effective use of alprazolam tablets.

What are the ingredients in alprazolam tablets?
Active ingredient: alprazolam, USP
Inactive ingredients: colloidal silicon dioxide, corn starch, docusate sodium, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and sodium benzoate. The 0.5 mg tablet also contains FD&C yellow #6 aluminum lake (sunset yellow lake). The 1 mg tablet also contains FD&C blue #2 aluminum lake. The 2 mg tablet also contains D&C yellow #10 aluminum lake.

This Medication Guide has been approved by the U.S. Food and Drug Administration.

Manufactured by:
Actavis Elizabeth LLC
Elizabeth, NJ 07207 USA

Distributed by:
Actavis Pharma, Inc.
Parsippany, NJ 07054 USA

Revised – July 2017


(MG 41-1233/0717)

Revised: 8/2018
Aphena Pharma Solutions - Tennessee, LLC